Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Galapagos Targets Liver Fibrosis With Evotec Deal

Feb 07 2019

• By John Davis

Liver — Liver fibrosis has been targeted by a number of pharma companies • Source: Shutterstock

Related Content

Gilead Maintains Optimistic Outlook For Yescarta Despite Slow Growth

Feb 05 2019

Rheumatoid Arthritis Data Position Filgotinib Ahead Of Competition, But It's Playing Catch-Up

Sep 12 2018

Gilead/Galapagos' Trailing JAK1 Filgotinib Boosted By AS Trial

Sep 06 2018

Related Companies

Galapagos NV

Evotec SE

Fibrocor Therapeutics L.P.

Gilead Sciences, Inc.

Pfizer Inc.

Eli Lilly and Company

AbbVie Inc.

Additional Topics

Clinical Trials Deals Commercial Liver & Hepatic Metabolic Disorders BioPharmaceutical

More from Clinical Trials

More from R&D

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.